Session Details
[2PS-09]【J】Academic Drug Development Conference 2025
Thu. Dec 4, 2025 2:20 PM - 4:20 PM JST
Thu. Dec 4, 2025 5:20 AM - 7:20 AM UTC
Thu. Dec 4, 2025 5:20 AM - 7:20 AM UTC
Room 9(Pacifico Yokohama Conference Center 4F, 411+412)
Organizer: Yoshiki Ikeda (Kyoto University), Kirara Inoue (Osaka Metropolitan University)
Nowadays, as academia has become more prevalent in drug discovery, many seeds that are new to academia have been generated. However, it is also true that only about 1% of these seeds result in joint research. This gap is largely due to the awareness of both parties regarding drug discovery. In order to bridge this gap, attention is being paid to needs, i.e. the voice of patients. It will be difficult to overcome difficult diseases unless we build a system that is sensitive to needs, respects each other, and works together to advance development. This conference will deepen the discussion by focusing on pharmaceutical and technological development that focuses on medical needs, and explore the path to drug discovery that can be created jointly between academia and companies.
Introduction
[2PS-09-01]Identification of a Novel Membrane Protein involved in Crosstalk between Hepatocyte and Hepatic Stellate Cell
○Kirara Inoue1,2, Tsutomu Matsubara3, Hayato Urushima3, Hideto Yuasa3, Atsuko Daikoku3, Norifumi Kawada4, Katsutoshi Yoshizato5, Takayuki Suzuki1, Misako Matsubara5,6 (1. Developmental Biology, Graduate School of Science, Osaka Metropolitan University, 2. Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, 3. Anatomy and Regenerative Biology, Graduate School of Medicine, Osaka Metropolitan University, 4. Endowsed Departments of Liver Cancer Treatment and Homeostatic Regulation, Graduate School of Medicine, Osaka Metropolitan University, 5. Donated Laboratory for Synthetic Biology, Graduate School of Medicine, Osaka Metropolitan University, 6. Cellular and Molecular Biology, Graduate School of Veterinary Science, Osaka Metropolitan University)
[2PS-09-02]Elucidation of GPCR-TRP channel crosstalk mechanisms and its implication for drug discovery
○Sakura N306 Moriyama1,2, Shuji Hinuma2, Shun'ichi Kuroda1,2 (1. Univ. of Osaka, Graduate School of Frontier Biosciences, 2. Univ. of Osaka, SANKEN)
[2PS-09-03]Drosophila-Based Human Cancer Xenograft Model and Perspectives for Drug Discovery Applications
○Erina Kuranaga1,2 (1. Kyoto University, 2. Tohoku University)
[2PS-09-04(2P-971)]Therapeutic Target Discovery for Rare Diseases via Machine Learning Integrating GWAS and TWAS
○Satoko Namba1, Michio Iwata2, Shin-Ichi Nureki3, Noriko Yuyama Otani1, Yoshihiro Yamanishi1 (1. Dept. of Complex Systems Science, Grad. Sch. of Informatics, Nagoya Univ., 2. Dept. of Bioscience and Bioinformatics, Fac. of Comp. Sci. and Systems Eng., Kyushu Inst. of Tech., 3. Dept. of Respiratory Medicine and Infectious Diseases, Fac. of Medicine, Oita Univ.)
[2PS-09-05(2P-782)]AMP-Atlas: AI-Driven Discovery and Evolutionary Optimization of Antimicrobial Peptides
○Yuki Otani1,2, Daisuke Koga1, Tae Ugaki1, Yasunari Wakizaka1, Hideyuki Shimizu1,2 (1. Institute of Integrated Research, Instiute of Sceince Tokyo, 2. Graduate School of Medical and Dental Science, Institute of Science)
[2PS-09-06(2P-304)]Interaction Analysis of Designable LNP with Membrane-mimetic SUVs to Elucidate the Mechanism of Cell Tropism (Second report)
○Kozue Furuya1, Shu Okumura1, Masaaki Takada1, Mitsuko Sugano1 (1. Toshiba Corporation)
[2PS-09-07]Development of small molecules that transiently open the blood-brain barrier and deliver drugs to the brain
Saito Inoue1, Keisuke Shirakura1, Atsuya Shirono1, Yoshiki Ikeda2, Jumpei Taguchi3, Satomi Tomita3, Keisuke Tachibana1, Kazutake Tsujikawa1, Takamitsu Hosoya3, Hirouki Takeda4, Masuo Kondoh1,5, Yasushi Fujio1,5, ○Yoshiaki Okada1,5 (1. The University of Osaka, Grad. Sch. Pharm. Sci., 2. Kyoto Univ., 3. Institute of Science Tokyo, 4. Ehime Univ., 5. The University of Osaka, CiDER)
[2PS-09-08]Academic Mission in Drug Discovery for Parasitic Infections
○SAKAMOTO Hirokazu1,2 (1. Chiba University, 2. NIID, JIHS)
[2PS-09-09]Towards the global expansion of infertility treatment drugs
○Yoshiki Ikeda1, Toru Matsu-ura2, Naoko Yoshida2, Tatsuya Kobayashi3, Pham Thi Tam2, Miki Okabe4, Kyoko Higuchi3, Keiichi Takahashi4, Keizo Tokuhiro5, Yoshiko Hashimoto6,7, Hidetaka Okada7, Koji Tsuta2 (1. Institute for Integrated Cell-Material Sciences, Kyoto University, 2. Department of Pathology, Kansai Medical University, 3. Fujita Medical Innovation Center Tokyo, Fujtia Health University, 4. Takahashi Women’s Clinic, 5. Department of Genome Editing, Kansai Medical University, 6. Department of Obstetrics and Gynecology, Suita Tokushukai Hospital, 7. Department of Obstetrics and Gynecology, Kansai Medical University)